121 related articles for article (PubMed ID: 10465265)
1. Differential effects of insulin-like growth factor I (IGF-I) and IGF-binding protein-1 on protein metabolism in human skeletal muscle cells.
Frost RA; Lang CH
Endocrinology; 1999 Sep; 140(9):3962-70. PubMed ID: 10465265
[TBL] [Abstract][Full Text] [Related]
2. Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factor-I stimulated protein synthesis.
Frost RA; Lang CH; Gelato MC
Endocrinology; 1997 Oct; 138(10):4153-9. PubMed ID: 9322924
[TBL] [Abstract][Full Text] [Related]
3. Alcohol impairs protein synthesis and degradation in cultured skeletal muscle cells.
Hong-Brown LQ; Frost RA; Lang CH
Alcohol Clin Exp Res; 2001 Sep; 25(9):1373-82. PubMed ID: 11584159
[TBL] [Abstract][Full Text] [Related]
4. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication.
Clemmons DR; Horvitz G; Engleman W; Nichols T; Moralez A; Nickols GA
Endocrinology; 1999 Oct; 140(10):4616-21. PubMed ID: 10499518
[TBL] [Abstract][Full Text] [Related]
5. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells.
Zheng B; Clemmons DR
Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11217-22. PubMed ID: 9736716
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone stimulates protein synthesis in bovine skeletal muscle cells without altering insulin-like growth factor-I mRNA expression.
Ge X; Yu J; Jiang H
J Anim Sci; 2012 Apr; 90(4):1126-33. PubMed ID: 22100600
[TBL] [Abstract][Full Text] [Related]
8. The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro.
Burch WM; Correa J; Shively JE; Powell DR
J Clin Endocrinol Metab; 1990 Jan; 70(1):173-80. PubMed ID: 1688439
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I blocks dexamethasone-induced protein degradation in cultured myotubes by inhibiting multiple proteolytic pathways: 2002 ABA paper.
Li BG; Hasselgren PO; Fang CH; Warden GD
J Burn Care Rehabil; 2004; 25(1):112-8. PubMed ID: 14726748
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM
Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077
[TBL] [Abstract][Full Text] [Related]
12. Insulin and insulin-like growth factor-I enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms.
Fryburg DA; Jahn LA; Hill SA; Oliveras DM; Barrett EJ
J Clin Invest; 1995 Oct; 96(4):1722-9. PubMed ID: 7560063
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of sepsis on ability of leucine and IGF-I to stimulate muscle translation initiation.
Lang CH; Frost RA
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E721-30. PubMed ID: 15186995
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 (IGF-1) and leucine activate pig myogenic satellite cells through mammalian target of rapamycin (mTOR) pathway.
Han B; Tong J; Zhu MJ; Ma C; Du M
Mol Reprod Dev; 2008 May; 75(5):810-7. PubMed ID: 18033679
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein (IGFBP) inhibits IGF action on human osteosarcoma cells.
Campbell PG; Novak JF
J Cell Physiol; 1991 Nov; 149(2):293-300. PubMed ID: 1721071
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia.
Vary TC; Dardevet D; Grizard J; Voisin L; Buffiere C; Denis P; Breuille D; Obled C
Am J Physiol; 1998 Oct; 275(4):E584-93. PubMed ID: 9755076
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility.
Zhang X; Yee D
Cancer Res; 2002 Aug; 62(15):4369-75. PubMed ID: 12154042
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I.
Brink M; Price SR; Chrast J; Bailey JL; Anwar A; Mitch WE; Delafontaine P
Endocrinology; 2001 Apr; 142(4):1489-96. PubMed ID: 11250929
[TBL] [Abstract][Full Text] [Related]
19. A novel PKB/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle.
Lai YC; Liu Y; Jacobs R; Rider MH
Biochem J; 2012 Oct; 447(1):137-47. PubMed ID: 22793019
[TBL] [Abstract][Full Text] [Related]
20. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.
Furlanetto RW; DiCarlo JN; Wisehart C
J Clin Endocrinol Metab; 1987 Jun; 64(6):1142-9. PubMed ID: 2952664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
